Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
CYANOCOBALAMIN- cyanocobalamin injection, USP
Its important to tell your injection or infusion provider if you are taking certain medications, as they may not interact well with the B12
Also, the cyanocobalamin medication is approved for use in humans as well and has some slight differences in ingredients compared to the 100mL bottle of injectable B-12, which could affect cost
:max_bytes(150000):strip_icc()/GettyImages-1331502792-cdc8ea8d1bb3486d96111406aff3ae34.jpg)
US$ 27.44
US$ 28.26
US$ 27.28
